OpGen Inc (OPGN) USD0.01
OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information of products and services for global healthcare settings to guide clinicians with information about infections, improve patient outcomes and decrease the spread of infections caused by multidrug-resistant organisms (MDROs). The Company’s molecular diagnostics and informatics product candidates and services combine its Unyvero and Acuitas molecular diagnostics and Ares Genetics’ database and the Acuitas Lighthouse informatics platform.The molecular diagnostic tests provide microbial identification and antibiotic resistance gene information. The Acuitas Lighthouse informatics systems are cloud-based informatics offerings, which are designed to combine clinical lab test results with patient.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.